Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in EOLS — Evolus, Inc.

CIK 80255 BALTIMORE, MD
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$956,061
+$553,429 QoQ
Shares Held
137,761
+40.6% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. EOLS ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 68,214,436 $1,083,245,243
2 ALKS
Alkermes plc.
 6,737,328 $353,035,986
3 LNTH
Lantheus Holdings, Inc.
 1,903,354 $211,158,092
4 LQDA
Liquidia Corp
 1,940,364 $154,705,221
5 UTHR
UNITED THERAPEUTICS Corp
 243,444 $131,905,262
6 PRGO
PERRIGO Co plc
 8,700,421 $90,397,373
7 ZTS
Zoetis Inc.
 1,139,097 $81,855,510
8 TEVA
Teva Pharmaceutical Industries Ltd
 1,679,152 $56,889,668

All Filings in EOLS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $956,061 137,761
2026-03-31 $402,632 97,964
2025-12-31 $567,670 85,364
2025-09-30 $388,876 63,335
2025-06-30 $518,734 56,323
2025-03-31 $657,186 54,629
2024-12-31 $580,626 52,593
2024-09-30 $749,428 46,261
2024-06-30 $494,911 45,614
2024-03-31 $558,348 39,882
2023-12-31 $402,719 38,245
2023-09-30 $341,772 37,393
2023-06-30 $266,096 36,602
2023-03-31 $294,137 34,768
2022-12-31 $255,790 34,060
2022-09-30 $269,948 33,534
2022-06-30 $298,247 25,711
2022-03-31 $377,384 33,635
2021-12-31 $271,759 41,745
2021-09-30 $178,650 23,445
2021-06-30 $342,119 27,045
2021-03-31 $542,774 41,784